Nirav Patel, DPM
Podiatrist · Philadelphia, PANPI 1538658349
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,445 of the $2,148 with a category attached, or 67.2%. Stryker accounts for 68.7% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $1,151 and has fallen 77.2% since, to $262 in 2025.
Across 44 payments — averaging $48.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Organogenesis Inc.$156
- Biocomposites Inc$103
- Lifenet Health$56
- Globus Medical$48
- Linvatec Corporation$46
- plus $264 from 11 others
What the payments were for
- Travel & lodging$70433%
- Food & beverage$1,44567%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 19 | $1,475 |
| Organogenesis Inc. | 5 | $156 |
| Biocomposites Inc | 3 | $103 |
| Lifenet Health | 2 | $56 |
| Globus Medical | 1 | $48 |
| Linvatec Corporation | 1 | $46 |
| AbbVie | 2 | $45 |
| Averitas Pharma Inc. | 2 | $38 |
| Johnson & Johnson | 1 | $27 |
| IBSA Pharma Inc. | 1 | $24 |
| Next Science LLC | 1 | $23 |
| Bioventus LLC | 1 | $21 |
| Sanara Medtech Inc. | 1 | $20 |
| Smith+Nephew | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Convatec Inc. | 1 | $15 |
| Mimedx Group, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,148 in reported general payments places this provider in the 70th percentile of 445 podiatrist providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 155 | $3,700 |
| Diclofenac Sodium | 38 | $1,047 |
| Ammonium Lactate | 51 | $806 |
| Ciclopirox | 34 | $637 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 23 | $497 |
| Doxycycline Hyclate | 63 | $437 |
| Methylprednisolone | 60 | $391 |
| Mupirocin | 33 | $290 |
| Cephalexin | 54 | $254 |
| Ibuprofen | 17 | $65 |
| Oxycodone Hcl | 13 | $54 |
| Meloxicam | 36 | $36 |
| Tramadol Hcl | 11 | $29 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Philadelphia
- Daniel PerezPhiladelphia$434K
- Kwasi KwaaduPhiladelphia$65K
- Luke CicchinelliPhiladelphia$62K
- James McGuirePhiladelphia$60K
- Richard JayPhiladelphia$10K
- Elena WellensPhiladelphia$8K
- Kieran MahanPhiladelphia$6K
- Ashmi ShahPhiladelphia$6K
- Mark HofbauerBelle Vernon$1.1M
- Christopher BarrettChester$229K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.